Not yet recruiting NCT07640360

Smartwatch-Guided Secondary Prevention After Stroke

No phase Interventional Stroke Transient Ischemic Attack

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Smartwatch-Guided Secondary Prevention after Stroke.
Who it may be relevant to: Registry conditions: Stroke, Transient Ischemic Attack. Basic parameters: 40 years — 75 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: France
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

WATCH-STEP : Pilot Trial: Smartwatch-Guided Secondary Prevention After Stroke Randomized Trial of Nurse-led Program With Active vs Passive Smartwatch in Minor Stroke. A Randomized Controlled Trial Evaluating a Nurse-led Secondary Prevention and Physical Activity Program Supported by Either an Active Smartwatch (Structured Feedback) or Passive Smartwatch in Patients With Minor Stroke.

Overview

After a first stroke or transient ischemic attack (TIA), the risk of recurrence is high in the weeks and months following the initial event. There are several modifiable risk factors that can reduce this risk, such as blood pressure, diet, physical activity, and smoking. Many stroke patients (NIHSS \< 5) have a low daily step count during the early recovery period, despite a good functional prognosis. Active smartwatches provide real-time feedback, track progress, and set personalized walking goals, thereby boosting motivation and adherence to physical activity recommendations. The combination of advice provided by nurses and active behavioral coaching supported by a smartwatch, compared to passive monitoring, could significantly increase daily step counts over a 12-week period. The results of this research will help guide future large-scale secondary prevention strategies integrating digital health and structured nursing support.

Detailed description

To meet the study's objectives, 50 patients who have recently suffered a stroke or a transient ischemic attack (TIA) (\< 30 days) will be recruited at Brest University Hospital.

Participation in this study will last 12 weeks. It consists of 3 visits, described below:

=\> Visit #1: Enrollment (hospital)

Enrollment will take place during a routine hospital visit. The investigator will obtain the patient's written consent. Randomization will then be performed to assign the patient to a group ("active" or "passive" watch).

For all patients ("active" and "passive" watch groups):

* Program led by nurses, conducted as part of routine care following a recent ischemic stroke or TIA (secondary prevention). * Issuance of a smartwatch and a smartphone * Data collection (sociodemographic information, medical history, current treatments, risk factors) * Questionnaires * Clinical examination, neurological examination, and blood draw.

For patients in the "passive" smartwatch group:

o The smartwatch will collect data passively, without notifications.

For patients in the "active" smartwatch group:

* Setting daily step goals and assessing potential obstacles * Scheduling regular calls (twice a week) for the duration of the study.

* Visit #2: Phone call

For all patients (both "active" and "passive" watch):

* Phone contact to collect data on changes in risk factors and the occurrence of events of interest (stroke, TIA, and cardiovascular events). * Questionnaires

* Visit #3: End of study (hospital)

The end-of-study visit will take place at the hospital during a scheduled routine care appointment:

* Assessment with a nurse as part of the secondary prevention program (routine care) * Data collection (risk factors) * Questionnaires * Clinical examination, neurological examination, and blood draw * Return of the smartwatch and smartphone

Interventions

Other Smartwatch-Guided Secondary Prevention after Stroke
Setting daily walking goals, assessing obstacles Regular phone calls (twice a week) to review progress, adjust goals, and provide support

Primary outcome measures

To determine whether the addition of an active smartwatch providing structured feedback to a nurse-led activity program produces a significantly greater increase in daily step count over 12 weeks compared with the same program paired with a passive smart [Time frame: Week 12]

Secondary outcome measures (12)

To evaluate feasibility to smartwatch wear [Time frame: Week 6 and Week 12]
To evaluate adherence to smartwatch wear [Time frame: Week 6 and Week 12]
To evaluate acceptability of digital feedback. [Time frame: Week 6 and Week 12]
To assess the impact of active smartwatch feedback on sedentary time. [Time frame: day 1 to week 12]
To assess the impact of active smartwatch feedback on gait-related activity patterns. [Time frame: day 1 to week 12]
To assess the impact of active smartwatch feedback on blood pressure. [Time frame: day 1 to week 12]
To monitor falls [Time frame: day 1 to week 12]
To monitor cardiovascular events (atrial fibrillation, AF), [Time frame: day 1 to week 12]
To examine effects on quality of life [Time frame: day 1 to week 12]
To examine effects on risk factors [Time frame: Day 1, week 6 and week 12]
Recurrence and cardiovascular events [Time frame: day 1 to week 12]
To examine effects on fatigue [Time frame: day 1 to week 12]

Eligibility criteria

Inclusion criteria

Age ≤ 40-75
Patients with recent minor ischemic stroke or TIA, initial NIHSS ≤5 (< 30 days)
mRS ≤2 before stroke and on discharge
Patient with Wifi access (for data transmission)
Able to understand smartwatch instructions
Written informed consent
Ambulatory ≥10 meters without assistance and without walking aid
Expected to live at home during the study period.

Exclusion criteria

Patients with transient neurological deficits resolving within one hour and normal brain imaging will be excluded
Not affiliated to social security
Patient under legal protection or deprived of liberty by a judicial or administrative decision
Patient whose follow-up will be impossible
Cognitive impairment interfering with participation (e.g., MoCA <20).
Unstable cardiac conditions preventing walking goals.
Major visual or upper limb impairment preventing use of the smartwatch.
Life expectancy <1 year.
Already highly active (>10,000 steps/day, or about 1.5 hours of walking).
Participation in competing interventional trials.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation: Randomized
Model: Parallel assignment
Masking: Open label
Primary purpose: Prevention

Study locations

France · 1 center

CHU Brest — Brest

Identifiers

NCT: NCT07640360 · 29BRC23.0208

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗